West Legalworks Webinar: Contingent Capital

01 Dec 2010 01:00 p.m. - 02:00 p.m. EST

Christie Adams
(212) 336-4024

Contingent capital products have been hailed as a possible solution to bolstering regulatory capital levels for financial institutions. Generically, a contingent capital instrument is a hybrid security (having certain equity-like and certain debt-like features), which can serve to provide permanent capital for the financial institution issuer during stress scenarios. Thus far, we have seen two issuances of contingent capital, one in an exchange offer by Lloyds and another in an offering by Rabobank. We will place contingent capital instruments on the hybrid product continuum, and discuss the current regulatory capital developments (in Dodd-Frank and in the Basell III framework) that have stimulated the debate about contingent capital, as well as the securities, tax and other structuring considerations.

The Panel Will Address:

  • Dodd-Frank regulatory capital provisions,
  • Basel III capital provisions,
  • Various contingent capital structures,
  • Disclosure issues,
  • Tax considerations,
  • Other structuring considerations, and
  • Rating agency and investor concerns.


  • Thomas A. Humphreys
    Morrison & Foerster LLP
  • Anna T. Pinedo
    Morrison & Foerster LLP
  • Anthony Ragozino
    Managing Director – Head of Capital Products
    UBS Investment Bank

Contact Christie Adams at cadams@mofo.com for a client discount code.

West Legalworks will provide CLE credit.




Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.